GSK’s consumer health spinout Haleon has acquired exclusive US rights to commercialise the gel-based product, called MED3000 ... Belgium in March under the Eroxon brand name, under an agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback